Provexis, announced the resignation of Frédéric Boned, a Non-executive Director of the Company, with immediate effect. Frédéric Boned joined the Board of Provexis as a Non-executive Director in July 2018, at which point he was EMEA Vice President of DSM's Human Nutrition & Health business, a part of DSM Nutritional Products. Frédéric, who is currently Regional Vice President Health Nutrition & Care North America at DSM, has announced his resignation from DSM with effect from 15 October 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 GBX | -4.00% | +0.50% | -7.69% |
Apr. 03 | Quiz sales fall, names new CEO; Byotrol eyes AIM exit | AN |
2023 | Provexis plc Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-7.69% | 18.09M | |
+4.94% | 7.74B | |
+2.93% | 5.92B | |
-5.09% | 3.77B | |
-11.51% | 3.52B | |
-12.06% | 1.23B | |
-30.14% | 1.04B | |
+15.98% | 988M | |
-8.94% | 929M | |
-14.02% | 823M |
- Stock Market
- Equities
- PXS Stock
- News Provexis plc
- Provexis plc Announces Directorate Change